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Abstract
Background: Over the last two decades an increasing number of countries have legalized euthanasia and
physician-assisted suicide (EAS) leading to considerable debate over the inherent ethical dilemmas. Increasing
numbers of people with personality disorders, faced with unbearable suffering, have requested and received
assistance in terminating their lives. EAS in people with personality disorders has, however, received very sparse
attention from clinicians and researchers. In this paper, we examine the literature on the practice and prevalence of
EAS in people with personality disorders to date and discuss the associated challenges for research and practice.
Methods: Narrative review of the literature combined with the authors’ collective experience and knowledge of
personality disorders.
Results: In six of the eight countries where EAS is currently legal, mental disorders are accepted as disorders for
which EAS may be granted. In four of these countries, EAS in minors with mental disorders is also accepted. Our
literature search resulted in 9 papers on the subject of EAS in people with personality disorders. These studies
suggest that most clinicians who grant EAS have indeed perceived their patients’ suffering as chronic, unbearable
and untreatable without prospect of improvement. The majority of patients with personality disorders had tried
some form of psychotherapy, but very few had received any of the relevant evidence-based treatments. The
decision to grant EAS based on a perception of the patient’s illness as being untreatable with no prospect of
improvement, could, thus, in many cases fail to meet the due care criteria listed in EAS laws. People with
personality disorders more often wish for death for extended periods of time than people without these disorders.
However, there is ample empirical data to show that suicidal tendencies and behaviour can be treated and that
they fluctuate rapidly over time.
Conclusions: In light of our findings, we believe that the current legislation and practice of EAS for people with
personality disorders is based on an inadequate understanding of underlying psychopathology and a lack of
awareness about the contemporary treatment literature. Moreover, we assert that this practice neglects the
individual’s potential for having a life worth living.
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Background
On February 20th 2020 Portugal’s parliament provisionally
approved a bill to legalize euthanasia and physician-assisted
suicide (in the following collectively labelled EAS), thus join-
ing a burgeoning group of nations who have chosen to per-
mit what has for many centuries, remained a prohibited and
morally condemned practice. Similar legislative changes are
currently taking place in other countries. Invariably, what
motivates legislators to decriminalize EAS, is to end what is
considered as unbearable, untreatable and unnecessary suf-
fering in people with incurable illness and, thus, assisting a
peaceful death. Although somatic suffering is almost always
the main focus of law-makers attention, life-ending assist-
ance for people with mental illness has become more com-
mon in recent years. Over the past decade, we have
identified the fact that an increasing number of people with
personality disorders (PD) have requested and received EAS.
Nevertheless, EAS in this group has received very sparse at-
tention. In this paper, we examine the literature on the prac-
tice and prevalence of EAS in people with PD to date,
discuss associated challenges and provide recommendations
for policy makers, clinicians and researchers.
A brief history of euthanasia
The Greek term euthanasia (ε θανασία) denotes a good
(eu) death (thanatos) and was from antiquity originally
not associated with physician-assisted dying, but
regarded as a natural and highly desirable course at the
end of one’s life [1]. Indeed, under the Hippocratic oath,
any kind of assisted dying is explicitly forbidden [2]. In
the medieval period and early modern age, euthanasia
was generally prohibited and it was only at the beginning
of the sixteenth century that so-called “mercy killing”
was openly discussed and supported by some philoso-
phers and ethicists. Euthanasia was regarded as a facilita-
tion of dying, assisted by physicians and potentially, but
not necessarily, shortening life [1]. In the late 19th and
early 20th centuries, on the background of Darwinism
and the Eugenics Movement, euthanasia became more
frequently discussed and practiced, culminating in the
ideology and practices embraced by the Nazi regime in
Germany, where so-called “Gnadentod” (German for
“mercy death”) became a euphemistic term for the coor-
dinated killing of mentally ill and physically or mentally
disabled people who did not fit into the prevailing ideal
of human beings. As a consequence, in German-
speaking countries the term “euthanasia” is still nega-
tively charged and has, thus, been banned from the
societal discourse and replaced by the term “aktive
Sterbehilfe”, which is close to the English term “assisted
dying”. This linguistic situation is different in many
other countries in the world, where euthanasia in the
public eye seems to represent a more or less desirable
facilitation of death without pain or other suffering.
A contemporary definition of euthanasia is proposed
by Denys [3]: “Euthanasia means that the physician acts
directly to end the patient’s life, e.g., by giving a lethal
injection”. In contrast “Physician-assisted Suicide” (PAS)
is the situation in which a physician provides the specific
means and instructions to a patient with the intention of
ending the patient’s life, but where the patient him/her-
self performs the act of ending his or her life [4]. In
1942, Switzerland was the first country to legalize PAS
but not euthanasia. However, according to Swiss legal
practice, the latter will not be punished, if it is delivered
free of selfish motives [5]. After 2001, seven more
countries have legalized PAS and/or euthanasia (for
an overview see Table 1). The Netherlands, Belgium,
Luxembourg as well as Colombia and Canada now all
permit euthanasia, whereas Switzerland, parts of
Australia (the state of Victoria), and ten states of the
USA only legalized PAS. In addition, the legislature of
New Zealand has just recently allowed euthanasia, but
the final decision will be made in a referendum in
2020. In Germany the Federal Constitutional Court
(Germany’s highest court) in February 2020 over-
turned a ban on organized assisted suicide, thus de-
claring that the right to die includes the freedom to
rely on the voluntary help of another person. In all of
the countries having legalized PAS and/or euthanasia,
so far, more or less detailed procedures have been de-
scribed as requirements for directly or indirectly help-
ing people to die. Usually, an examination by a
medical doctor has to take place, and the person has
to be able to decide freely without being influenced
by any relevant cognitive impairment or external
pressure.
Although PAS or euthanasia were originally intended
to facilitate death without pain or other suffering from
physical illness, people with mental illness have gradually
also been considered eligible.
Methods
This paper is based on a narrative review of the litera-
ture combined with the authors’ collective experience
and knowledge of personality disorders from extensive
clinical practice, clinical research and treatment develop-
ment, and involvement in the formulation of national
policy in relation to the management of personality
disorder.
Literature search
We searched the Medline database (OVID) for peer
reviewed articles and letters to the Editor published in Eng-
lish through October, 2019 with the following MeSH-terms:
“Euthanasia”, “Euthanasia, Active”, “Euthanasia, Active, Vol-
untary”, “Suicide, Assisted”, “Personality Disorders” and “Bor-
derline Personality Disorder”. No language or time filters
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were applied. The literature search resulted in 9 papers; 2
regular articles based on empirical studies, 4 literature re-
views and 3 comments/letters to the editor. In the following,
we summarise the main findings and conclusions from these
publications.
Results
Table 1 provides an overview of the legislation on eu-
thanasia and physician-assisted suicide in the different
countries where it is established. The majority of the
countries allowing EAS restrict it to people above the
age of 18 years, whereas the Netherlands offer both PAS
and euthanasia from the age of 12 years, Colombia per-
mits PAS in children after the age of 5 years, and
Belgium has abolished any age limit (Table 1).
In the case of Belgium, the law requires a repeated
wish from the child himself and permission from parents
(except in the case of so-called ‘emancipated minors’
where a minor, through court order or other means, le-
gally becomes an adult). Few cases of EAS in minors have
so far been reported; all in cases of physical illness. Some
countries allow EAS in mentally ill people, provided they
are considered able to express their free will (this is not re-
quired by Colombia and Australia, but here EAS is not
permitted for psychiatric reasons). To be granted euthan-
asia in Belgium, to date the country with the most liberal
EAS legislation, a person must be “in a medically futile
condition of unbearable and untreatable physical or psy-
chological suffering, resulting from a serious and incurable
disorder caused by accident or illness” [6]. The Federal
Control and Evaluation Committee on Euthanasia in
Table 1 Overview of the legislation on euthanasia and physician-assisted suicide in the different countries where it is established
Country Netherlands Belgium Luxemburg Switzerland Colombia Canada AustraliaVictoria USAOregon,
Washington,
Montana,
Vermont,
California, District
of Columbia,
Colorado, New
Jersey, Maine,
Hawaii
Entry into
force of
law
2001 2002 2009 1942 2015 2016 2017 2008–2019
Physician-
assisted
suicide
(PAS)
+ + + + + + + +
Euthanasia
(EUT)
+ + + – + + – –
Allowed to
be given
to mentally
ill
PAS/EUT PAS/EUT PAS/EUT PAS – PAS/EUT – PAS
Age limit ≥12 no limit ≥18 No regulation,
but usually
only applied
≥18
≥6 ≥18 ≥18 ≥18
Reference https://english.
euthanasiecommissie.
nl/
http://www.
ethical-
perspectives.
be/viewpic.
php?LAN=
E&TABLE=
EP&ID=59
http://www.
ejustice.just.
fgov.be/
mopdf/2
014/
03/12_1.
pdf#Page67
(Dutch and
French
language)
https://guichet.
public.lu/de/
citoyens/
famille/
euthanasie-
soins-palliatifs/
fin-de-vie/
euthanasie-
assistance-
suicide.html
(German
language)
http://legilux.
public.lu/eli/
etat/leg/loi/2
009/03/16/n2/jo
(French
language)
https://www.
admin.ch/opc/
en/classified-
compilation/1
9370083/index.
html
https://www.
bj.admin.ch/bj/
en/home/
gesellschaft/
gesetzgebung/
archiv/
sterbehilfe/
formen.html
https://www.
minsalud.gov.
co/
Normatividad_
Nuevo/
Resolución%2
01216%2
0de%202015.
pdf
(Spanish
language)
López-
Benavides
2018
https://
www.
canada.
ca/en/
health-
canada/
services/
medical-
assistance-
dying.
html
https://end-of-
life.qut.edu.au/
euthanasia
https://www2.
health.vic.gov.
au/hospitals-
and-health-
services/
patient-care/
end-of-life-
care/voluntary-
assisted-dying
www.
deathwithdignity.
org
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Belgium reports [7] that about of 3% of EAS-cases are
mainly linked to mental disorders. Thienpont and col-
leagues [8] conducted a retrospective analysis of medical
records of the first 100 consecutive patients (23 men and
77 women) who requested euthanasia for psychological
suffering associated with mental disorders in the years be-
tween 2007 and 2011. The most common of these disor-
ders were treatment resistant mood disorders (n = 58) and
personality disorders (n = 50), whereas 29 patients had
both types of disorder. Among the 50 patients with a PD,
27 had borderline PD (BPD), 3 had dependent PD, 2 had
histrionic PD and 18 had some other PD or PD not other-
wise specified. In all patients with PD suffering was re-
ported to be chronic, constant and unbearable, “without
prospects of improvement, due to treatment resistance”
[8]. The study does not specify or operationalize the con-
cept of “treatment resistance” or how it was measured. In
total, 48 of all of the 100 euthanasia requests were ac-
cepted, of which 35 were carried out, but the authors do
not specify how many of these had a PD diagnosis.
In 2018, 4% of all deaths in the Netherlands were due
to EAS, and among all cases of EAS (N = 6126) around
1% involved patients with a mental disorder according
to the Dutch regional euthanasia review committees
(RTE) [9]. Since 2013 the RTE has published all psychi-
atric cases of EAS on their website. Kim and co-workers
reviewed the first 66 psychiatric cases of EAS published
and found that 52% of these were patients with personal-
ity disorders or difficulties [10]. The prevalence of PD
was higher in patients who were younger. Recently, a
larger Dutch study based on content analysis was pub-
lished by Nicolini et al. [11]. Among the 116 cases pub-
lished by the RTE, a diagnosis of PD was likely,
according to the authors’ clinical judgement, in just
under two-thirds of cases (n = 74), although a PD diag-
nosis had been explicitly made by the patients’ doctors
in only 48 (41%) cases. The majority (72%) of patients
with PD had received some form of psychotherapy, but
mostly of unspecific nature, and only one patient (1%)
had received any of the standard PD-specific evidence-
based treatments currently in existence.
Most of the people who request EAS for mental illness
appear to be experiencing multiple mental health prob-
lems. In the study by Kim et al. [10] depressive disorders
(55%), posttraumatic stress disorder and other anxiety
disorders (42%) were prominent whereas 52% of the pa-
tients had personality-related problems, sometimes with-
out a formal PD diagnosis, more so in younger patients.
Social isolation or loneliness were mentioned in 56% of
the cases.
Discussion
Our review of the literature suggests that a large propor-
tion of people with mental disorders who request and
receive EAS are people with personality disorders. It is
difficult to reach firm conclusions about prevalence fig-
ures and proportions based on the limited number of
studies and cases reported in each study. Yet, we think
these findings make for disturbing reading, particularly
in light of the time-sensitive changes that can occur in
the psychopathology of personality disorder. We con-
sider this issue further below.
Personality disorders and the wish for death
Suicidal and self-harming behaviours are frequently seen
in people with personality disorders, in particular border-
line personality disorder (BPD), where this is one of the
diagnostic criteria [12]. Emotional and behavioural dysreg-
ulation is characteristic of BPD and is closely linked to sui-
cidal behaviour [13]. In addition, suicidal behaviour in
people with BPD is often linked to the wish to seek help,
to communicate or to solve interpersonal problems. An
important aspect of BPD individuals’ problems is their dif-
ficulty with regulating their relationships with other
people maintaining nurturing close interpersonal relation-
ships over time [14]. This extends to the clinical setting
where patients with BPD all too often feel disappointed,
rejected or invalidated by their therapists and thus termin-
ate treatment at an early stage [15].
A wish for death and an increased risk of suicide may be
prominent, although less well documented, among people
with other personality disorders. In narcissistic personality
disorder, there is frequently a hypersensitivity to the evalua-
tions of others and a fluctuation in the self-esteem between
grandiose and depleted states, depending on life circum-
stances [16, 17]; these are personality features associated
with an increased risk of both suicidal and non-suicidal
self-injury [18, 19]. Suicidal behaviour is frequently seen in
people with antisocial personality disorder, where it is often
associated with severe problems in interpersonal relations
and with the justice system.
It follows from the above that people with personality
disorders on average more often contemplate death and
may have a stronger wish for death for more extended
periods of time than is the case for people without these
disorders. We have, however, no data to suggest that
these tendencies of thinking about suicide or wishing for
suicide are completely immutable to change. Rather they
are very likely learnt dysfunctional behaviours, and they
fluctuate rapidly. An individual who frequently experi-
ences strong and painful feelings of helplessness, sadness
and entrapment may find that thinking of death and sui-
cide will offer some sense of control (“I can stop the
pain”) and relief. Thus, it will be likely that this person
will be more inclined to think about suicide next time
the painful feelings become overwhelming. This rein-
forced pattern of frequently thinking of and/or wishing
for death and suicide is very familiar to many people
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with BPD and other personality disorders [20], but it
may seem difficult to accept or to understand for other
people, including health-care personnel. In turn, this fre-
quently leads to a host of dysfunctional transactions be-
tween people with severe PDs and their families and
carers.
Under the principle of self-determination, it can be ar-
gued that only patients themselves can be the judge of
what is best for them and that it should not be up to
doctors to make interpretations of a patient’s wish for
death. Whereas we respect this principle, it is still the
duty of clinicians to provide due care and use their
knowledge to act in accordance with what they believe is
in the best interest of their patient. This is also empha-
sized in the due care criteria in several of the current
laws and guidelines for EAS, for example in the Dutch
guideline where it mentions explicitly that if the wish for
death is a symptom of a mental disorder, it should be
treated and not lead to EAS.
We believe that in contexts where EAS for people with
PDs is available, particularly precarious circumstances
are present, with the potential for adverse consequences.
Frequent suicidal communications and requests for EAS
may lead carers to underestimate the basic criterion for
granting such requests; that the patient’s situation must
entail unbearable suffering with no prospect of improve-
ment and no alternative to end the suffering. However,
in most cases even severe suicidal tendencies and self-
harming behaviour can be treated and individuals can be
helped to recover. We must emphasize that a range of
psychosocial interventions, including cognitive-
behavioural therapy, dialectical behaviour therapy and
mentalization based therapy have all been shown to re-
duce suicidal and self-harming behaviour in randomized
trials with both adolescents [21] and adults [22]. Admit-
tedly, even though effects of specialized treatments are
good for the average patient, some patients are non-
responders or even deteriorate or drop out early. We
would argue that, in cases of non-response, patients with
PD should be offered an alternative evidence-based
treatment before EAS is considered. Currently, we don’t
know how large proportion of patients with PD request-
ing euthanasia could have been treated effectively, and
how big the group is who would not respond to even
the best of treatments. There is a great need for more
studies to shed light over these important questions.
The transactional aspects of asking for and granting of
EAS in patients with PD
A request for EAS from a severely ill patient, in reality,
may be a request for communication about loneliness or
mental suffering, or an attempt by the patient to find a
reason to continue living through eliciting a dialogue
with his/her doctor or mental health worker [23].
Studies have shown, however, that people with BPD have
significant difficulties with correctly appraising other
people’s emotions and intentions through observing
their facial expressions [24]. They frequently associate
neutral faces as expressions of sadness, aggression or
disgust. Such difficulties could result in patients believ-
ing that their physicians agree with them that they
would be better off dead. To our knowledge, there are
no empirical studies of whether, and how frequently,
such misperceptions occur in the context of requests for
EAS and whether they have a significant influence on
the outcome of these requests. In our experience, this is
just one of several possible mechanisms through which
patients and their carers might severely miscommunicate
with respect to requests for and granting of EAS.
Authors writing about EAS from a psychodynamic
perspective have highlighted that a request for EAS may
be viewed as an expression of rage at the physician for a
variety of reasons – for example, appearing to give up
(or indeed giving up) on the patient, or not provide a
cure [25]. Clinicians often find it hard to work with
these clients because being close to someone who is in
unbearable emotional pain is difficult. Furthermore, cli-
nicians frequently experience their transaction with pa-
tients with BPD as more difficult and demanding than
with other patients. This is very accurately described by
the well-known American psychiatrist Allen Frances as
follows: “Most of us have a much greater immediate em-
pathy for a patient’s depression or anxiety, and even for
violent impulses and psychotic thinking, than we do for
the relief some patients feel when they hurt and scar
themselves. The typical clinician (myself included) treat-
ing a patient who self-mutilates is often left feeling some
combination of helpless, horrified, guilty, furious,
betrayed, disgusted and sad” [26].
Again, it is important to remember that our know-
ledge on what influences physicians’ decisions when
dealing with requests for EAS is very limited due to a se-
vere lack of research in this field. However, in a Dutch
study, a lower proportion of physicians found it conceiv-
able that they would grant EAS in patients with mental
illnesses (34%) than the proportion who found it con-
ceivable that they would grant EAS in patients with
physical illnesses, such as cancer (85%) [27]. Interest-
ingly, general practitioners were 2.6 times more likely
than clinical specialists to find it conceivable that they
would grant EAS in patients with mental illnesses. This
could mean that with higher level of clinical expertise
may follow a reduced willingness to grant EAS for men-
tal illnesses.
Patients with BPD and suicidal and self-harming be-
haviours are typically regarded as being hard to treat.
This seems to have been the case with patients with PD
in the study of Thienpont et al. [8] who were perceived
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as being “untreatable”. However, the question whether
patients with PD are untreatable or “uncurable”, as
demanded by Belgian law, is debatable. The most preva-
lent PD diagnosis in this particular study was Borderline
PD, which although often a long-term condition, is not,
contrary to popular belief, an incurable disorder. Over
the past twenty years, treatment studies have flourished
showing that a diverse range of manualized treatments
for BPD such as dialectical behaviour therapy (DBT),
transference-focused psychotherapy (TFP), mentalization
based therapy (MBT), or schema therapy are effective
with medium to large effect sizes and remission achiev-
able in a high percentage of cases [28, 29]. National
guidelines (e.g. in Germany or the UK) recommend one
of the evidence-based psychotherapies mentioned above
as first-line treatment [30]. They also stress the import-
ance of careful delivery and supervision of these treat-
ments by trained therapists, and the potential benefit of
adjunctive psychotropic medication for symptom relief.
Currently, there is a scarcity of research into the ques-
tion of whether patients with PD who requested EAS
were offered evidence-based PD-specific treatment. We
think, however, that it is doubtful whether these guide-
lines have been followed in the majority of individuals
with BPD who have requested EAS. We strongly recom-
mend that adherence to guidelines for state-of-the art
treatment for PDs, and BPD in particular, are included
in the decision-making process underpinning EAS
applications.
Conclusions and recommendations
Based on the scant published literature, we have serious
concerns about the practice emerging in an increasing
number of countries of facilitating EAS for people with
personality disorders. This appears to be based on faulty
assumptions about the underlying psychopathology and
a lack of awareness about the contemporary treatment
literature, particularly on borderline personality disorder.
First, we would argue that wishes for death or suicide,
even when clearly articulated by the patient to doctors
or next-of-kin, and even if it represents the true will at
that very moment, this desire or wish for death will
likely change in many of these cases. As we have pointed
out above, such an articulated death wish, can be a
symptom of the disorder and may in reality convey sev-
eral other possible messages, that have more to do with
the patient feeling abandoned, disappointed or angry. It
may also convey a wish for help to live rather than a
wish for help to die. Second, we would claim that the
notion of personality disorders as “untreatable” condi-
tions and “without prospects of improvement” are based
on outdated knowledge about the state of PD treatment.
Today, a range of effective psychotherapeutic interven-
tions are available for people with personality disorders
in most of the countries that have so far legalized EAS.
That this has seemingly escaped the attention of both
legislators and expert medical communities is deeply dis-
turbing. It may be that the current lack of effective psy-
chotropic medication to treat personality disorders could
have made many physicians and psychiatrists not spe-
cializing in PD treatment less optimistic about the prog-
nosis in people with PDs and the prospects of receiving
effective treatment in general. We urgently call for a re-
vision of the current legislation and practice of EAS for
people with personality disorders which we believe, is
currently based on an inadequate understanding of these
peoples’ needs and their potentials for having a life
worth living.
We recommend that professionals involved in making
decisions regarding granting of EAS as a minimum
should receive training covering a) insight in the fluctu-
ating nature of suicidal thinking and its emotion regula-
tion function, b) the evidence that PD – but especially
BPD – is treatable, c) the risk of miscommunication
around this issue given the impairments in identifying /
reading emotions in others combined with a sense of be-
ing a burden to others and d) an examination of their
own attitudes and beliefs towards suicidal and self-harm
behaviour with particular attention to their own emo-
tional responses. We further recommend that EAS
Guidance should require that clients with BPD should
have had a substantial period of treatment in at least
two of the evidence-based approaches from an appropri-
ately trained and supervised clinical team which has led
to no noticeable improvement before EAS can be con-
sidered. Given the high likelihood of change in presenta-
tion of any mental disorder in minors, EAS should not
be considered on the grounds of any established or
emerging mental disorder for those under 18 years. Fi-
nally, we recommend legislators involved in EAS legisla-
tion and policy making should make provisions for
funding of research into the current practice of EAS in
people with mental disorders.
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